FGFR1 and cancer: Alterations in FGFR1 have been reported in 3.63% of all cancers, with breast carcinoma, non-small cell lung carcinoma, colorectal adenocarcinoma, malignant glioma and ovarian neoplasms showing the greatest prevalence of abnormalities [26].